Loading insider details...
Beta
Latest Form 4 (Apr 24, 2026): Sale of 10,000 ARWR shares, $750.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 24, 2026 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 10,000 | $750.0K |
| Mar 9, 2026 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 10,000 | $641.9K |
| Jan 8, 2026 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 75,000 | n/a |
| Jan 6, 2026 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 4,625 | $283.2K |
| Oct 3, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 20,000 | $700.0K |
| Sep 16, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 15,000 | $450.0K |
| Sep 4, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 15,000 | $375.0K |
| Aug 15, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 611 | $12.2K |
| Jan 8, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 100,000 | n/a |
| Apr 3, 2024 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 6,000 | $168.2K |